CREATIVE MEDICAL TECHNOLOGY (CELZ) Stock Balance Sheet
NASDAQ:CELZ - Nasdaq - US22529Y4089 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 5.94M | 3.47M | 8.32M | 10.72M | 100.00K | |||
| Marketable Securities | 0.00 | 6.52M | N/A | N/A | N/A | |||
| Receivables | N/A | N/A | 0.00 | 0.00 | 0.00 | |||
| Inventories | 2.20K | 6.60K | 10.00K | 10.00K | N/A | |||
| Other Current Assets | 192.70K | 277.30K | 10.42M | 3.28K | N/A | |||
| Total Current Assets | 6.14M | 10.27M | 18.75M | 10.74M | 100.00K | |||
| Non-Current Assets | ||||||||
| Intangibles | 530.60K | 441.00K | 440.00K | 530.00K | 620.00K | |||
| Other Non-Current Assets | 3.30K | 3.30K | 0.00 | 0.00 | N/A | |||
| Total Non-Current Assets | 533.80K | 444.30K | 440.00K | 530.00K | 620.00K | |||
| TOTAL ASSETS | 6.67M | 10.72M | 19.19M | 11.27M | 720.00K | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 790.00K | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 39.90K | 39.90K | 40.00K | 20.00K | 160.00K | |||
| Accounts Payable | 273.50K | 317.30K | 3.27M | 760.00K | 350.00K | |||
| Other Current Liabilities | 14.20K | 14.20K | 10.00K | 260.00K | 39.22M | |||
| Total Current Liabilities | 327.60K | 371.40K | 3.32M | 1.05M | 40.52M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Non-Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| TOTAL LIABILITIES | 327.60K | 371.40K | 3.32M | 1.05M | 40.52M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -64.59M | -59.10M | -53.81M | -43.67M | -61.89M | |||
| Additional Paid In Capital | 70.93M | 69.71M | 69.66M | 53.88M | 21.32M | |||
| Common Shares | 1.80K | 1.40K | 10.00K | 10.00K | 770.00K | |||
| Treasury Stock | 0.00 | -271.00K | N/A | N/A | N/A | |||
| Shares Outstanding | 1.75M | 1.37M | 1.41M | 630.00K | 150.00K | |||
| Tangible Book Value per Share | 3.32 | 7.21 | 10.94 | 15.38 | -269.47 | |||
| Total Shareholders' Equity | 6.34M | 10.34M | 15.86M | 10.22M | -39.80M | |||
| TOTAL LIABILITIES AND EQUITY | 6.67M | 10.72M | 19.19M | 11.27M | 720.00K | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 18.73 | 27.65 | 5.65 | 10.23 | 0.00 | |||
| Return On Assets (ROA) | -82.37% | -49.34% | -52.84% | 170.45% | -5045.83% | |||
| Return On Equity (ROE) | -86.63% | -51.11% | -63.93% | 187.96% | N/A | |||
All data in USD , ROIC based on taxRate of 0.21